Catalyst Wire Dossier Catalyst Wire Dossier

Bone marrow mesenchymal stem cell-derived extracellular vesicles infusion

· Direct Biologics, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bone marrow mesenchymal stem cell-derived extracellular vesicles infusion, covering 2024-07-29 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS [Phase 1, Phase 2]

See pricing